NASDAQ:LIPO
Lipella Pharmaceuticals Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.lipella.comipo date
Dec 19, 2022
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus